<DOC>
	<DOCNO>NCT00600067</DOCNO>
	<brief_summary>The purpose study determine long-term safety efficacy VI-0521 ( phentermine/topiramate ) compare placebo provide blood sugar control Type 2 diabetic adult . Continuation initial 6 month trial .</brief_summary>
	<brief_title>A VI-0521 Study Evaluate Long-term Safety Efficacy Type 2 Diabetic Adults</brief_title>
	<detailed_description />
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>Have complete qualify OB202 trial If female childbearing potential , subject must use adequate contraception Provide write informed consent Be willing able comply schedule study visit , treatment plan , lab test study procedure Subjects develop one morbidity OB202 trial would pose safety concern</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Glucose Metabolism Disorders</keyword>
	<keyword>Glycemic Control</keyword>
</DOC>